MBAI
$1.76
Post-MarketAs of Mar 17, 8:00 PM UTC
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.76
Potential Upside
5%
Whystock Fair Value$1.85
Price
UndervaluedFair ValueOvervalued
Fundamentals
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$12.83M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.82
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-130.12%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.71
